Use of Sentinel Cells for the Development of Molecular Tests to Control the Quality of Cryopreservation

N/AWithdrawnNCT01904825

Centre Hospitalier Universitaire Dijon

Overview

The aim is to set up tools that will serve as quality tracers for cryopreservation procedures. To meet this objective, we have chosen to develop reference samples (sentinel cells) that, in the medium term, can be used as controls to guarantee the quality of preservation for biological samples. The biological tools and an optimised follow-up strategy will make it possible to validate preservation procedures at the CRB in order to guarantee the perfect stability of samples and the validity of clinical studies.

Study Type

OBSERVATIONAL

Conditions

Aneurysm of the Abdominal Aorta

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \> or = 18 years * All patients presenting an abdominal aorta diameter of at least 5 cm at the time of discovery and who have surgery Exclusion Criteria: * Patients who do not have aneurysm of the abdominal aorta * Refusal to sign the consent form for participation * Patients who do not wish to have their operation in Dijon or Strasbourg CHU

Outcomes

Primary Outcomes

Quality sentinel cells

Time frame: participants will be followed for the duration of hospital stay, an expected average of 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.